Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.672
Delayed Data
As of 3:59pm ET
 -0.0007 / -0.10%
Today’s Change
0.36
Today|||52-Week Range
2.67
+80.55%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close0.67
Today’s open0.70
Day’s range0.66 - 0.71
Volume4,357,513
Average volume (3 months)6,165,064
Market cap$102.3M
Dividend yield--
Data as of 3:59pm ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)+35.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+100.00%
P/E ratioNM
Price/Sales150.86
Price/Book3.46

Competitors

 Today’s
change
Today’s
% change
PFNXPfenex Inc-0.01-0.23%
PLXProtalix Biotherapeu...0.000.00%
NVIVInVivo Therapeutics ...-0.30-10.53%
CBMGCellular Biomedicine...+0.35+4.43%
Data as of 4:02pm ET, 06/26/2017

Financials

Last reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$200.0K
Annual profit (last year)-$50.8M
Net profit margin-25,385.61%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Operating &
Medical Officer
Daniel J. Levitt
Corporate headquarters
Los Angeles, California

Forecasts